
Journal of Medicinal Chemistry p. 1084 - 1104 (2020)
Update date:2022-08-15
Topics:
Kurasawa, Osamu
Miyazaki, Tohru
Homma, Misaki
Oguro, Yuya
Imada, Takashi
Uchiyama, Noriko
Iwai, Kenichi
Yamamoto, Yukiko
Ohori, Momoko
Hara, Hideto
Sugimoto, Hiroshi
Iwata, Kentaro
Skene, Robert
Hoffman, Isaac
Ohashi, Akihiro
Nomura, Toshiyuki
Cho, Nobuo
In our pursuit of developing a novel, potent, and selective cell division cycle 7 (Cdc7) inhibitor, we optimized the previously reported thieno[3,2-d]pyrimidinone analogue I showing time-dependent Cdc7 kinase inhibition and slow dissociation kinetics. These medicinal chemistry efforts led to the identification of compound 3d, which exhibited potent cellular activity, excellent kinase selectivity, and antitumor efficacy in a COLO205 xenograft mouse model. However, the issue of formaldehyde adduct formation emerged during a detailed study of 3d, which was deemed an obstacle to further development. A structure-based approach to circumvent the adduct formation culminated in the discovery of compound 11b (TAK-931) possessing a quinuclidine moiety as a preclinical candidate. In this paper, the design, synthesis, and biological evaluation of this series of compounds will be presented.
View More
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Guangzhou Flower's Song Fine Chemical CO,. Ltd
Contact:+86-20-87475199
Address:No.12, Fenghuang 3 Road, Jiulong Industrial Park, Luogang District, Guangzhou. China
Contact:0086 371 65711996
Address:Jalan 4/3, Kawasan Perindustrian Serendah, 48000 Rawang,
Contact:027-87677569
Address:Room 2203, yujingmingmen Buidling One, xiongchu Road, wuhan city, hubei province, China
Arshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
Doi:10.1246/bcsj.62.3691
(1989)Doi:10.1007/BF00912610
(1974)Doi:10.1016/S0040-4020(01)91019-1
(1991)Doi:10.1021/acs.orglett.7b04042
(2018)Doi:10.1021/jacs.9b11601
(2019)Doi:10.1002/jlac.197419740208
(1974)